199 related articles for article (PubMed ID: 34575665)
1. Analysis of SYK Gene as a Prognostic Biomarker and Suggested Potential Bioactive Phytochemicals as an Alternative Therapeutic Option for Colorectal Cancer: An In-Silico Pharmaco-Informatics Investigation.
Biswas P; Dey D; Rahman A; Islam MA; Susmi TF; Kaium MA; Hasan MN; Rahman MDH; Mahmud S; Saleh MA; Paul P; Rahman MR; Al Saber M; Song H; Rahman MA; Kim B
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575665
[TBL] [Abstract][Full Text] [Related]
2. Study of
Biswas P; Bibi S; Yousafi Q; Mehmood A; Saleem S; Ihsan A; Dey D; Hasan Zilani MN; Hasan MN; Saleem R; Awaji AA; Fahmy UA; Abdel-Daim MM
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049742
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of Syk gene methylation in colorectal cancer.
Bu F; Zhu X; Liu S; Lin K; Zhu J; Huang J
Immun Inflamm Dis; 2021 Sep; 9(3):923-931. PubMed ID: 33979042
[TBL] [Abstract][Full Text] [Related]
4. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
6. Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression.
Ni B; Hu J; Chen D; Li L; Chen D; Wang J; Wang L
Oncol Lett; 2016 Sep; 12(3):1737-1744. PubMed ID: 27602108
[TBL] [Abstract][Full Text] [Related]
7. Systematic Analysis of Spleen Tyrosine Kinase Expression and its Clinical Outcomes in Various Cancers.
Alwithenani AI; Althubiti MA
Saudi J Med Med Sci; 2020; 8(2):95-104. PubMed ID: 32587490
[TBL] [Abstract][Full Text] [Related]
8. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
[TBL] [Abstract][Full Text] [Related]
9. Transporter associated with antigen processing 1 (TAP1) expression and prognostic analysis in breast, lung, liver, and ovarian cancer.
Tabassum A; Samdani MN; Dhali TC; Alam R; Ahammad F; Samad A; Karpiński TM
J Mol Med (Berl); 2021 Sep; 99(9):1293-1309. PubMed ID: 34047812
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation and prognostic implication of Syk gene in human colorectal cancer.
Yang Z; Huo L; Chen H; Ni B; Xiang J; Kang L; Wang L; Peng J; Yuan Y; Wang J
Med Oncol; 2013; 30(2):586. PubMed ID: 23609194
[TBL] [Abstract][Full Text] [Related]
11. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
12. Targeting the splicing isoforms of spleen tyrosine kinase affects the viability of colorectal cancer cells.
Denis V; Cassagnard N; Del Rio M; Cornillot E; Bec N; Larroque C; Jeanson L; Jarlier M; Combès E; Robert B; Gongora C; Martineau P; Dariavach P
PLoS One; 2022; 17(9):e0274390. PubMed ID: 36103569
[TBL] [Abstract][Full Text] [Related]
13. A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer.
Laham AJ; El-Awady R; Lebrun JJ; Ayad MS
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454940
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
15. Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report.
Peng H; Huang J; Hu Y; Wei Y; Liu H; Huang M; Wang L; Wang J
Cell Oncol (Dordr); 2015 Apr; 38(2):165-72. PubMed ID: 25921550
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and Immunological Role of THBS2 in Colorectal cancer.
Deng B; Liu XP; Wang X
Biomed Res Int; 2021; 2021():1124985. PubMed ID: 34471634
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Significances and Prognostic Value of
Fu F; Niu R; Zheng M; Yang X; Fan L; Fu W; Zhang S
J Cancer; 2023; 14(1):24-34. PubMed ID: 36605492
[No Abstract] [Full Text] [Related]
18. SCARA5 is a Novel Biomarker in Colorectal Cancer by Comprehensive Analysis.
Liu J; Zeng ML; Shi PC; Cao YP; Zhang JL; Xie YP
Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658413
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
Wang QQ; Zhou YC; Zhou Ge YJ; Qin G; Yin TF; Zhao DY; Tan C; Yao SK
World J Clin Cases; 2022 Aug; 10(22):7686-7697. PubMed ID: 36158487
[TBL] [Abstract][Full Text] [Related]
20. The Impact of DTYMK as a Prognostic Marker in Colorectal Cancer.
Aloliqi AA; Fararjeh AF; Al-Khader A; Kaddumi E; Eisa AA; Jaradat W
World J Oncol; 2023 Feb; 14(1):84-93. PubMed ID: 36895992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
